Latest News in the pharma Industry

All

MAA submitted to EMA for patisiran for the treatment of hereditary ATTR amyloidosis

MAA submitted to EMA for patisiran for the treatment of hereditary ATTR amyloidosis

27 Dec 2017

Sanofi and Alnylam's patisiran MAA to be reviewed under accelerated assessment.

Read more 
FDA approves the only OTC eye drop with low-dose Brimonidine to treat eye redness

FDA approves the only OTC eye drop with low-dose Brimonidine to treat eye redness

27 Dec 2017

Clinical studies showed 95% symptom improvement at one minute and reduced redness for up t 8 hours.

Read more 
AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

AMSBIO introduces highly efficient substrate for culturing ES/iPS cells

27 Dec 2017

iMatrix recombinant Laminin-511 E8 protein fragments permit ES/iPS cells to be maintained in xeno-free, feeder-free culture conditions enabling easy application in medical trials.

Read more 
Allergan acknowledges Appeals Court decision for Combigan

Allergan acknowledges Appeals Court decision for Combigan

27 Dec 2017

Allergan plans to file petitions for rehearing of the appeals court decision and has asserted a new Orange Book patent against Sandoz's generic version of Combigan.

Read more 
Acerus receives Notice of Deficiency from Health Canada for Gynoflor

Acerus receives Notice of Deficiency from Health Canada for Gynoflor

27 Dec 2017

Health Canada requests additional technical information on Gynoflor to complete its assessment of the product.

Read more 
FiH trial of new immunotherapy approach shows efficacy in antibiotic resistance

FiH trial of new immunotherapy approach shows efficacy in antibiotic resistance

27 Dec 2017

Human polyclonal antibodies show promise as effective treatment.

Read more 
Crown Bioscience and JSR Corporation to merge

Crown Bioscience and JSR Corporation to merge

21 Dec 2017

Merger integrates Crown Bioscience’s leading translational technology platform providing drug target validation, efficacy testing and patient response characterization with JSR’s IVD solutions, GMP manufacturing capabilities and worldwide distribution ...

Read more 
Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA

21 Dec 2017

New collaboration agreement to identify new antisense oligonucleotide drug candidates.

Read more 
FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A

19 Dec 2017

First and only FDA-cleared PK dosing software to support healthcare professionals in creating personalized dosing regimens for patients 16 and older with hemophilia A.

Read more 
Collaboration to develop innovative technologies

Collaboration to develop innovative technologies

20 Dec 2017

Project will innovate technologies in epigenetic characterisation for patient stratification in renowned precision medicine.

Read more 
NIH study uncovers clues about why common cancer drug causes hearing loss

NIH study uncovers clues about why common cancer drug causes hearing loss

20 Dec 2017

Researchers find target to protect hearing during chemotherapy treatment.

Read more 
Impax sells Taiwan manufacturing facility

Impax sells Taiwan manufacturing facility

20 Dec 2017

Bora Pharmaceuticals to pay purchase price of $18.5 million and will have the rights to market and sell Impax's branded Parkinson's drug Rytary (Numient outside the US) in Taiwan.

Read more